RMTI — Stock Film
STOCK FILMSCENE 1/11RMTI · $7.62
Stock Expert AI presents
RMTI
Rockwell Medical, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Rockwell Medical, Inc. A quick introduction.

On the stock market since 1998, it operates in the world of health and science. It has 157 employees. Now — the numbers.

on the stock market since 1998
157 employees
$29.5M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.1.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

In the vault right now:
$0
DEBT: $12.5M
At this pace, that money lasts about 4.7 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
2 / 8
EXPECTATIONS MET OR BEATEN
2
Nov 2024
Mar 2025
May 2025
Aug 2025
Nov 2025
Mar 2026
May 2026
Aug 2026
2 TIMES IN THE LAST 8 QUARTERS
It misses the bar more often than not.
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
61
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
38
weak

Clearly below the class average.

VALUATION
78
strong

Clearly above the class average — a step short of the very top.

GROWTH
4
very weak

Clearly below the class average.

PRICE MOMENTUM
26
very weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
A strong cash pile8/10
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Thin profit on each sale3/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 90% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Strong cash, light debt

There is $25.0M in the vault; even if every debt were paid off, $12.5M would remain.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 46 buys and 18 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $20.00162% above today’s price.

1
THE RISKS · 1/3
Running at a loss

A loss of $5.3M against $69.3M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 4/100.

3
THE RISKS · 3/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 26/100. For a turnaround signal, the stock first needs to close the gap with the market.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, RMTI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: RMTI is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film